tirzepatide long term use What to Know Before Starting for Medical Weight Loss Tirzepatide Long-Term Weight Loss: Safety
Description
Figure 6: Change in Body Weight (%) After 36-Week Open-Label Treatment Followed by Randomized Withdrawal (Study 4) in Patients with Obesity or Overweight Note: Displayed results are from the randomized population

National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 19902021, and forecasts up to 2050

Compounded tirzepatide is no longer available through regular pharmacies after March 19, 2025

Studies show that evening administration reduces nausea in up to 20% of patients by allowing peak GI effects to occur during sleep

Tirzepatide injections offer a broad range of benefits to those looking for support on their weight loss journey